Evidence map›Paper›PMID 39681858›Full record

ArticleParasites & vectors2024

Evidence for in vivo resistance against allopurinol in a dog infected with Leishmania infantum by reduction in copy numbers of the S-adenosylmethionine synthetase (METK) gene.

Ingo Schäfer, Mathieu Faucher, Yaarit Nachum-Biala, Lluís Ferrer, Marina Carrasco, Alexandra Kehl, Elisabeth Müller, Torsten J Naucke, Gad Baneth

Abstract readCase Reports
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Copy numbers of theCurrent research in parasitology & vector-borne diseases · 2026
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ingo SchäferLABOKLIN GmbH and Co. KG, Bad Kissingen, Germany. i.schaefer@laboklin.com.
Mathieu FaucherClinique Veterinaire Alliance, Bordeaux, France.
Yaarit Nachum-BialaKoret School of Veterinary Medicine, The Hebrew University, Rehovot, Israel.
Lluís FerrerNANO1HEALTH SL, Parc de Recerca UAB, 08193, Bellaterra, Barcelona, Spain.
Marina CarrascoNANO1HEALTH SL, Parc de Recerca UAB, 08193, Bellaterra, Barcelona, Spain.
Alexandra KehlLABOKLIN GmbH and Co. KG, Bad Kissingen, Germany.
Elisabeth MüllerLABOKLIN GmbH and Co. KG, Bad Kissingen, Germany.
Torsten J NauckeLABOKLIN GmbH and Co. KG, Bad Kissingen, Germany.
Gad BanethKoret School of Veterinary Medicine, The Hebrew University, Rehovot, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Europe, canine leishmaniasis is commonly caused by Leishmania infantum. Allopurinol is the main drug for long-term management of the disease, and clinical relapses of L. infantum infection treated with this drug are described. Resistance to allopurinol has been demonstrated in-vitro, but there is only little knowledge on in vivo resistance in dogs.

findingsA two-year-old female spayed Akita Inu that was adopted from a breeding facility near Nice in France was initially diagnosed with primary immune-mediated hemolytic anemia. Immunosuppressive treatment was initiated, and the dog was referred for a second opinion to the Clinique Veterinaire Alliance in France. PCR testing for L. infantum was performed out of EDTA blood and IFA as well as ELISA testing out of serum. Resistance to allopurinol was associated with chromosome and gene copy number (CN) variations including a decrease in the S-adenosylmethionine synthetase (METK) gene CN.

resultsThe dog showed pale mucous membranes, fever (39.1 °C), and a relapse of the anemia. The diagnosis of leishmaniasis was based on the cytological finding of Leishmania amastigotes (bone marrow, spleen, liver), positive PCR testing, and positive IFAT serology. The dog was treated with allopurinol over a period of 1316 days and additionally received two cycles of Glucantime® (meglumine antimoniate), before samples were submitted to the LABOKLIN laboratory to test for resistance against allopurinol. The laboratory work-up revealed mild thrombocytopenia, mild hyperproteinemia with hyperglobulinemia, a marked elevation of the c-reactive protein, and decreased iron concentration. Serum protein electrophoresis showed a polyclonal peak in the gamma globulins. Serology was positive in both ELISA (21.5 LE) and IFAT (1:1024). Quantitative PCR testing of blood was positive with low numbers of Leishmania (10/ml blood) at the timepoint of suspicion for resistance. The urinary protein-to-creatinine ratio was markedly elevated (2.5) and xanthine crystalluria was detected. A CN level of below 3 is considered suspicious for resistance, as revealed in the described Akita Inu dog.

conclusionsRelapse of L. infantum infection after applying allopurinol for 1316 days due to resistance was suspected clinically. Positive PCR testing, consistent hematological and biochemistry abnormalities, and reduction in the METK gene CN backed up the clinical suspicion of resistance. Dogs infected with allopurinol resistant strains of L. infantum may represent a great risk for infection of naïve dogs, cats, and humans.

Indexed as

AllopurinolDog DiseasesDrug ResistanceLeishmania infantumLeishmaniasis, VisceralAnimalsAntiprotozoal AgentsDogsFemaleFranceGene DosageMethionine AdenosyltransferaseAllopurinolAntiprotozoal AgentsMethionine AdenosyltransferaseLeishmaniasisTreatmentVector-borne infection

Identifiers

PMID39681858
PMCPMC11650845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.